Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
206 studies found for:    vaginitis
Show Display Options
Rank Status Study
21 Completed Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Intervention: Drug: estradiol, 25 mcg
22 Completed Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Intervention: Drug: estradiol, 25 mcg
23 Completed Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Intervention: Drug: estradiol, 10 mcg
24 Completed
Has Results
Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Intervention: Drug: estradiol, 10 mcg
25 Completed Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Interventions: Drug: estradiol, 10 mcg;   Drug: estradiol, 25 mcg
26 Recruiting Probiotics Capsule as Supplemental Therapy for Group B Streptococci Infection and Vaginitis During Pregnancy
Condition: Pregnancy
Interventions: Dietary Supplement: lactic acid bacteria;   Dietary Supplement: cranberry;   Dietary Supplement: placebo
27 Completed Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network
Condition: Vaginitis
Interventions: Drug: Terazol or oral fluconazole for candidal vaginitis;   Drug: Metronidazole or Clindamycin for Bacterial Vaginosis;   Drug: Flagyl for definitively diagnosed vaginal trichomoniasis;   Other: Empiric Management
28 Unknown  Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal Odor Not Caused by BV or Vaginitis
Condition: Vaginal Odor
Intervention: Device: WaterWorks Douching Device
29 Recruiting Vaginal Flora for Treatment of Bacterial Vaginosis
Condition: Recurrent Bacterial Vaginitis
Intervention: Biological: vaginal flora transplant
30 Completed Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis
Condition: Vaginitis
Interventions: Drug: MTZ vaginal gel;   Drug: Conventional MTZ vaginal gel
31 Completed Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Interventions: Drug: estradiol, 10 mcg;   Drug: estradiol, 25 mcg;   Drug: placebo
32 Completed Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463
Condition: Vaginal Infection
Interventions: Drug: TOL-463 Vaginal ovule;   Drug: TOL-463 Vaginal gel
33 Active, not recruiting Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
Conditions: Atrophic Vaginitis;   Breast Cancer
Intervention: Drug: Vagifem® (vaginal 17β-estradiol) questionnaire & menopause symptom checklist
34 Completed Observational Program Neo-Penotran® Forte
Conditions: Vaginal Candidiasis;   Bacterial Vaginosis;   Trichomonal Vaginitis
Intervention: Drug: Metronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276)
35 Completed Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis
Conditions: Bacterial Vaginosis;   Vulvovaginal Candidiasis;   Trichomoniasis
Intervention: Other: NAAT testing
36 Completed Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Intervention: Drug: estradiol, 25 mcg
37 Completed VS-Sense Result Reading Clarity
Condition: Vaginitis
Intervention: Device: vs-sense
38 Recruiting Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy
Conditions: Atrophic Vaginitis;   Menopause;   Vulvovaginal Atrophy
Interventions: Drug: Vaginal progesterone;   Drug: Placebo
39 Recruiting Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy
Conditions: Atrophic Vaginitis;   Menopause
Interventions: Device: CO2 fractionated vaginal laser;   Drug: Estrogens, Conjugated (USP)
40 Completed DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women
Condition: Trichomonas Vaginitis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.